Subject: Op risk data: TD Bank takes US reg pill in purported drug-related AML fails

WEEKLY ROUND-UP OF RISK MANAGEMENT ARTICLES
TOP STORY
Comment
Op risk data: TD Bank takes US reg pill in purported drug-related AML fails
Also: SCB fraud bill rising fast; Postbank pain for Deutsche Bank. Data by ORX News
16 May 2024   |  Opinion
Risk management
Clear warning on escape hatch for optimisation trades
CCPs fear Emir clearing mandate carve-out for portfolio rebalancing could be abused
13 May 2024   |  Feature
Risk management
One year on, regulators still want a cure for bank runs
Broad support for higher outflow assumptions on uninsured deposits, but that won’t save insolvent banks
10 May 2024   |  Feature
Comment
Falling T2 balances bode well for eurozone’s stability
Impact of fragmentation would be less severe today than in 2010s, says Marcello Minenna
01 May 2024   |  Opinion
Investing
For a growing number of banks, synthetics are the real deal
More lenders want to use SRTs to offload credit risk, but old hands say they have a long road ahead
01 May 2024   |  Feature
Risk management
Did Fed’s stress capital buffer blunt CCAR?
Experts fear flagship test’s use as a capital top-up has undermined its role in risk management
30 Apr 2024   |  Feature
Maximise your performance with Risk Learning
Risk Learning is the leading provider of exclusive, in-depth training for risk, finance and investment professionals. Learn from market leaders on the latest risk trends, from ESG reporting to treasury and capital markets risk, from operational risk to AI applications.
Learn more
Risk management
How Ally found the key to GenAI at the bottom of a teacup
Risk-and-tech chemistry – plus Microsoft’s flexibility – has seen US lender leap from experiments to execution
29 Apr 2024   |  Profile
Risk management
Industry urges focus on initial margin instead of intraday VM
CPMI-Iosco says scheduled variation margin is better than ad hoc calls by clearing houses
29 Apr 2024   |  News
Markets
Consortium backs BGC’s effort to challenge CME
Banks and market-makers – including BofA, Citi, Goldman, Jump and Tower – will have a 26% stake in FMX
25 Apr 2024   |  News
Regulation
Revealed: the three EU banks applying for IMA approval
BNP Paribas, Deutsche Bank and Intesa Sanpaolo ask ECB to use internal models for FRTB
24 Apr 2024   |  News

i

LinkedIn Apple Android Twitter Facebook